Bariatric Surgery Devices Market size to surpass $2 Bn by 2032

Bariatric Surgery Devices Market size is primed to reach USD 2 billion in revenue by 2032, according to a new research report by Global Market Insights Inc.
 

The surging demand for minimally invasive surgeries and growing instances of obesity as the chief drivers of bariatric surgery devices business trends. As per WHO, in 2022, over 650 million adults, 39 million children, and 340 million adolescents were suffering from obesity, which is speculated to reach approximately 167 million adults and children by 2025.
 

Additionally, strong government and non-government support for bariatric surgery are also foreseen to stimulate business expansion. For instance, the Murrumbidgee Local Health District’s Metabolic Obesity Service (MOS) provides education and bariatric surgery reimbursement support to patients falling under referral criteria.
 

Consistent developments in surgical devices to push demand for non-invasive devices

The bariatric surgery devices market into minimally invasive and non-invasive. The non-invasive surgical devices segment is projected to amass substantial gains through 2032 owing to rapid technological development and the introduction of new surgical technologies. For instance, in September 2022, Allurion, a U.S.-based medical device firm, launched the world’s first swallowable gastric balloon, Allurion Balloon, a non-surgical weight loss solution, in India. This innovative product restricts the size of the stomach and facilitates weight reduction.
 

Favorable reimbursement choices to augment the need for revision bariatric surgery

 The bariatric surgery devices market size from the revision bariatric surgery procedure segment is estimated to depict more than 6.5% CAGR between 2023 and 2032. As a result of weight regain after undergoing bariatric surgery for the first time, the necessity for revision surgery has increased drastically. Some patients also undergo stomach pouch expansion, which renders the first operation ineffective and necessitates revision of the bariatric procedure. According to studies, around 15-35% of patients who undergo gastric bypass surgery regain weight and need to undergo revision bariatric surgery to lose weight.
 

Browse key industry insights spread across 150 pages with 164 market data tables & 11 figures & charts from the report, “Bariatric Surgery Devices Market Size By Product (Minimally Invasive Surgical Devices [Stapling Devices, Energy/Vessel-sealing Devices, Suturing Devices], Non-invasive Surgical Devices), By Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Bariatric Surgery, Non-invasive Bariatric Surgery, Adjustable Gastric Banding, Mini-gastric Bypass), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” In detail along with the table of contents:
https://www.gminsights.com/industry-analysis/bariatric-surgery-devices-market
 

Increase in healthcare expenditure to bolster Europe industry share

Europe bariatric surgery devices market valuation is anticipated to reach over USD 645 million by 2032. The region may emerge as a major hub for this industry owing to mounting cases of obesity. According to the WHO, there are over 1.2 million deaths per year in Europe due to the rise in obesity, which is considered to be an obesity epidemic in the region. Meanwhile, healthcare policies and initiatives such as the National Health Service Act, along with the widespread use of bariatric surgery, are set to boost regional market expansion.
 

Product portfolio expansion to remain a key growth strategy

The strategic landscape is primed to witness industry players engage in acquisitions and mergers, along with product innovation, over the forecast years. The market includes Integra Life Sciences Holding Corporation, CONMED Corporation, B. Braun Melsungen AG, Grena Ltd., W. L. Gore & Associates, Ethicon Inc. (Johnson & Johnson), Cousin Biotech, Inc., and Intuitive Surgical, among other firms.